Bethlehem, Pa. (PRWEB) October 11, 2012
For the first time, B. Braun OEM Division (http://www.bbraunoem.com) will attend the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, October 15-17, in Chicago at the McCormick Place Convention Center. B. Braun OEM Division (Booth 1131) will promote products and packaging that pharmaceutical and biotech companies can use from their drug development through commercialization.
B. Braun products on display will include:
- Perfusor® Space Infusion Pump Systems and Extension Sets
- DUPLEX® Drug Delivery System
- EXCEL® IV Containers
- PAB® Partial Additive Bags
B. Braun OEM Division can provide standard products as well as custom products and fully packaged and sterilized procedure kits for the pharmaceutical market.
The 2012 AAPS Annual Meeting and Exposition (http://www.aaps.org/annualmeeting/) is a dynamic international forum for the exchange of knowledge among scientists to enhance their contributions to public health. The expected 9,000 attendees will include scientists working in drug design, discovery, development, delivery, packaging, scale-up, clinical trials, and regulatory sciences. The AAPS Annual Meeting will allow guests to meet their peers in all disciplines, discuss the latest research presented at Contributed Paper poster sessions, and discuss projects with current and new suppliers.
For more information, contact the B. Braun OEM Division toll free at 866-8-BBRAUN or visit http://www.bbraunoem.com.
About B. Braun OEM Division
B. Braun OEM Division (http://www.bbraunoem.com) delivers complete contract manufacturing capabilities focusing on fluid administration and admixture products, kits, valves, catheters and interventional accessories. OEM takes customers’ designs from the earliest stages through design prototyping, assembly, packaging and sterilization. The B. Braun OEM Division of B. Braun Medical Inc. is based in Bethlehem, Pa.
About B. Braun
Since the early 19th Century, B. Braun has met a myriad of challenges in modern medical therapy with meaningful and trusted solutions. The B. Braun group of companies, including B. Braun, Aesculap® and Central Admixture Pharmacy Services, Inc. (CAPS®), represent thousands of innovations in acute pain management and infusion therapy that are intended to improve care and lower costs while reducing risks to patients and workers. Guided by the company’s “Sharing Expertise®” philosophy, B. Braun works with motivated partners and customers to address the critical issues of infection prevention, medication safety and environmental responsibility.
The B. Braun corporate mission to bring solutions that lead to better patient care have earned the company dozens of awards, certifications and recognitions for innovative products, employment practices, “green” initiatives and community responsibility throughout the world. Consistently recognized by Frost & Sullivan for its medical technology and support services, B. Braun provides professional training through its Aesculap Academy, reaching over 45,000 healthcare professionals each year, teaching best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives. For more information, call 800-227-2862, e-mail us at firstname.lastname@example.org or visit B. Braun at http://www.bbraunusa.com.